NATCOPHARM / NSE / Biotechnology & Drugs
Natco Pharma
1Y Price Trend
Key Information
Recommendations
RatingHold
Target High1,226.1
Target Low789.3
Target Mean2.89
Target Median36.11
Risk Metrics
Overall RiskBalanced risk
Board Risk43.06
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
NATCO Pharma rallies after USFDA grants tentative approval for Olaparib tablets Business Standard
Natco Pharma Shares Gain After US FDA Tentative Approval for Generic Cancer Drug NDTV Profit
Natco Pharma shares surge 5% after US FDA's tentative nod Olaparib tablets The Economic Times
Stocks to Watch Today: Reliance Industries, ICICI Bank, HDFC Bank, NATCO Pharma, Oberoi Realty, RBL Bank,... Moneycontrol.com
Alembic partner NATCO gets USFDA nod for Olaparib scanx.trade
Natco Pharma receives USFDA tentative approval for generic Lynparza tablets CNBC TV18
Stock FAQs
What is the symbol and ISIN of Natco Pharma?
Natco Pharma has the symbol NATCOPHARM and ISIN - INE987B01026.
What is the current price of Natco Pharma?
Natco Pharma is currently trading at INR 945.00.
What are the year high and year low of Natco Pharma?
Natco Pharma has a year high of INR 1,226.10 and a year low of INR 789.30.
What is the market capitalization of Natco Pharma?
Natco Pharma has a market capitalization of INR 16,884.70 crore.
What is the P/E ratio of Natco Pharma?
Natco Pharma has a P/E ratio of 12.30.
What is the dividend yield of Natco Pharma?
Natco Pharma has a dividend yield of 0.52%.
How is the financial performance of Natco Pharma based on revenue, net income, and EPS?
Natco Pharma has revenue of INR 40,783.00 crore, net income of INR 14,185.00 crore, and EPS of INR 79.20.
What is the book value of Natco Pharma?
Natco Pharma has a book value of INR 500.46.
What is the debt-to-equity ratio of Natco Pharma?
Natco Pharma has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Natco Pharma?
Natco Pharma has a price-to-book ratio of 1.89 and a price-to-sales ratio of 0.41.
© SharekeyX | Rusaka Technologies 2024-2026

